A detailed history of Aviso Wealth Management transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Aviso Wealth Management holds 3,680 shares of GILD stock, worth $340,657. This represents 0.17% of its overall portfolio holdings.

Number of Shares
3,680
Previous 3,762 2.18%
Holding current value
$340,657
Previous $258 Million 19.54%
% of portfolio
0.17%
Previous 0.15%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$66.59 - $83.99 $5,460 - $6,887
-82 Reduced 2.18%
3,680 $309 Million
Q2 2024

Aug 14, 2024

SELL
$63.15 - $72.88 $9,346 - $10,786
-148 Reduced 3.79%
3,762 $258 Million
Q1 2024

May 14, 2024

BUY
$71.58 - $87.29 $10,021 - $12,220
140 Added 3.71%
3,910 $286 Million
Q4 2023

Feb 13, 2024

BUY
$73.27 - $83.09 $276,227 - $313,249
3,770 New
3,770 $305 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $116B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Aviso Wealth Management Portfolio

Follow Aviso Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aviso Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Aviso Wealth Management with notifications on news.